Capstone Investment Advisors
COGT icon

Capstone Investment Advisors’s Cogent Biosciences COGT Stock Holding History

Capstone Investment Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,120
Closed -$289K – 1666
2025
Q3 		$289K Buy
+20,120
New +$238K ﹤0.01% 1665
2024
Q1 		– Sell
-40,501
Closed -$238K – 2367
2023
Q4 		$238K Buy
+40,501
New +$310K ﹤0.01% 1703
2021
Q4 		– Sell
-12,928
Closed -$109K – 1878
2021
Q3 		$109K Buy
+12,928
New +$99.1K ﹤0.01% 1771
2021
Q1 		– Sell
-14,567
Closed -$164K – 1712
2020
Q4 		$164K Buy
+14,567
New +$160K ﹤0.01% 1486

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capstone Investment Advisors's COGT Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 20,120 shares — an estimated $289K sold.

Capstone Investment Advisors first reported a position in COGT in Q4 2020 and held it in 4 quarters. The position peaked at $289K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 20,120 Cogent Biosciences shares in Q4 2025, an estimated $289K.
  • Capstone Investment Advisors first reported a position in Cogent Biosciences in Q4 2020 and held it in 4 quarters.
  • Capstone Investment Advisors's Cogent Biosciences position peaked at $289K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.